Clinical Trials Browser

Carcinoma, Intraductal, Noninfiltrating, Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplastic Syndromes, Hereditary, Hereditary Breast and Ovarian Cancer Syndrome

NCT06574620 2026-01-16

ACCELERATE

Phase NA Recruiting

200 enrolled

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT06630104 2026-01-08

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Phase NA Recruiting

82 enrolled

LymphoidPlasma cell

Lymphoproliferative Disorders, Multiple Myeloma

NCT05868486 2026-01-02

Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer

Phase EARLY_PHASE1 Active not recruiting

100 enrolled

Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT04763980 2025-12-31

Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer

Phase NA Recruiting

72 enrolled

Genitourinary

Prostatic Neoplasms

NCT06744595 2025-12-12

Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer

Phase NA Enrolling by invitation

40 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT04447703 2025-12-02

Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

Phase NA Completed

346 enrolled

Genitourinary

Prostatic Neoplasms

NCT02620852 2025-11-25

WISDOM

Phase NA Recruiting

100,000 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT03731845 2025-11-20

ESIGON

Phase NA Active not recruiting

73 enrolled

BreastGynecologic

Breast Neoplasms, Primary Ovarian Insufficiency

NCT05649072 2025-11-19

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Phase NA Recruiting

1,000 enrolled

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT03460483 2025-10-03

OPTEC

Phase NA Completed

1,001 enrolled

GastrointestinalGynecologic

Colorectal Neoplasms, Hereditary Nonpolyposis, Endometrial Neoplasms

NCT07143487 2025-09-16

Family Communications After Genetic Testing

Phase NA Not yet recruiting

4,186 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT06843291 2025-02-24

UNIVERSAL GENETIC TESTING OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES (UGT)

Phase NA Not yet recruiting

100 enrolled

Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

NCT05591131 2025-02-21

GTM-I

Phase NA Active not recruiting

21 enrolled

Gynecologic

Ovarian Neoplasms, Endometrial Neoplasms

NCT03246841 2024-12-12

TUMOSPEC

Phase NA Active not recruiting

7,274 enrolled

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT04067960 2024-08-14

Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer

Phase EARLY_PHASE1 Completed

197 enrolled

CNSGastrointestinalGenitourinaryGynecologic

Brain Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

NCT06363162 2024-04-12

Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery

Phase NA Recruiting

200 enrolled

CNS

Glioma

NCT04002986 2023-07-24

Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot

Phase NA Completed

116 enrolled

Breast

Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8

NCT04456140 2023-07-24

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Phase 1 Completed

230 enrolled

BreastCNSGastrointestinalHead & Neck

Brain Neoplasms, Breast Neoplasms, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms, Unknown Primary, Urogenital Neoplasms, Central Nervous System Neoplasms

NCT02664389 2020-06-30

PANEL

Phase NA Completed

289 enrolled

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT01460186 2019-01-15

StoRM

Phase NA Completed

1,000 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01850654 2018-06-28

OCCPI

Phase NA Completed

3,470 enrolled

GastrointestinalGynecologic

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT03338985 2018-01-05

Role of Senescence in the Development of Endometrial Cancer

Phase NA Unknown

140 enrolled

Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT03337516 2017-11-09

Interest of a Therapeutic Follow-up of the Cytarabine in the Acute Myeloid Leukaemia: Is There Constitutional Biomarkers

Phase NA Unknown

40 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02422732 2015-08-19

Functional Imaging and Reading Deficit in Children With NF1

Phase NA Completed

25 enrolled

CNS

Dyslexia, Neurofibromatosis 1

Clinical Trials

PREDICT

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

Cancer Genetic Testing in Ethnic Populations

Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer

PROTECT-C

Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer

Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

ANDROLIPO

Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)

Identifying and Caring for Individuals With Inherited Cancer Syndrome

ACCELERATE

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer

Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer

Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer

Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

WISDOM

ESIGON

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

OPTEC

Family Communications After Genetic Testing

UNIVERSAL GENETIC TESTING OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES (UGT)

GTM-I

TUMOSPEC

Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer

Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery

Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

PANEL

StoRM

OCCPI

Role of Senescence in the Development of Endometrial Cancer

Interest of a Therapeutic Follow-up of the Cytarabine in the Acute Myeloid Leukaemia: Is There Constitutional Biomarkers

Functional Imaging and Reading Deficit in Children With NF1